Sangamo BioSciences | SGMO - Stock

Stock Price
0.26
Daily Change
-0.01 -5.26%
Monthly
-23.61%
Yearly
-67.04%
Q2 Forecast
0.26

Sangamo BioSciences reported $0 in Stock for its fiscal quarter ending in March of 2022.





Stock Change Date
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
Amgen USD 6.22B 121M Dec/2025
Bayer EUR 12.33B 221M Sep/2025
BioCryst Pharmaceuticals USD 5.4M 166K Dec/2025
Biogen USD 2.17B 41.3M Dec/2025
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Cipla INR 61.6B 5.18B Sep/2025
Clal Biotechnology ILS 4.44M 0 Mar/2021
CSL USD 6.47B 327M Jun/2025
Gilead Sciences USD 1.78B 40M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Grifols EUR 3.56B 63.19M Dec/2024
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
J&J USD 14.19B 45M Dec/2025
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Merck USD 6.44B 157M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Omeros USD 712K 266K Sep/2021
Pfizer USD 11.47B 201M Sep/2025
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025
Sarepta Therapeutics USD 914.74M 162.42M Dec/2025
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025